- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.06. | Fujifilm, Coherus, ViGeneron unveil rebrands to better reflect ongoing work | ||
| 05.06. | Amneal recalls 3 lots of a generic antibiotic after black spots found on tablets | ||
| 05.06. | Schott Pharma throws down €100M to build new sterile cartridge facility at Hungary manufacturing site | ||
| 04.06. | Novo Nordisk signs on to support ADA's obesity advocacy division | ||
| 04.06. | Bayer gains key FDA expansion for fast-rising prostate cancer drug Nubeqa | ||
| 04.06. | CDC vaccine expert resigns amid shifting COVID guidance: Reuters | ||
| 04.06. | Novartis marketing breach sparks PMCPA call for companies to be 'on high alert' | ||
| 04.06. | Biosynthesis specialist and Narcan ingredient maker Antheia reels in $56M in series C funding | ||
| 03.06. | ASCO: J&J highlights Rybrevant-Lazcluze combo in 'Breathtaking Moments' lung cancer campaign high over Chicago skyline | ||
| 03.06. | Agenus transfers pair of CA production plants to Zydus as part of $141M partnership | ||
| 02.06. | Science-led storytelling takes center stage in pharma communications | ||
| 02.06. | Endo maps out Men's Health Month awareness, education drive | ||
| 02.06. | With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint Medicines for $9.1B | ||
| 02.06. | Theravance hands off the last of its Trelegy royalties to GSK for $225M | ||
| 02.06. | Moderna's next-gen COVID shot gets FDA backing with some limitations | ||
| 02.06. | Regulatory tracker: Eton wins FDA nod for Khindivi, the first hydrocortisone oral solution | ||
| 30.05. | After holding out, bluebird bio investors get on board with sale to Carlyle, SK Capital | ||
| 30.05. | AbbVie flies the W against cancer with Chicago Cubs partnership, ASCO corporate campaign | ||
| 30.05. | Senator grills Makary over FDA's ability to regulate drug ads after OPDP cuts | ||
| 30.05. | Astellas organizes action week to connect patients to advocacy groups | ||
| 30.05. | Akeso, Summit's ivonescimab delayed progression by 48% in certain lung cancers in first global phase 3 readout | ||
| 29.05. | 'Hanging on by our fingernails': Stealth CEO questions efficiency behind FDA rejection of rare disease drug | ||
| 29.05. | Sanofi spices up Type 1 diabetes awareness with sponsorship of new UK girl group | ||
| 29.05. | Alcon gains first FDA prescription drug nod since Novartis split, scoring with drops for dry eye disease | ||
| 29.05. | Drugmakers, trade groups and others voice concerns with pharma-specific tariffs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .